Search Within

Neeta Pandit-Taskar

  1. "Epidemiology and Biostatistics"
Formats
  1. Journal Article (30)
  2. Meeting Abstract (21)
Groups
  1. Epidemiology and Biostatistics (51)
  2. Molecular Imaging and Therapy Service (51)
  3. Radiology, Department of (51)
  4. Biostatistics Service (50)
  5. GSK Faculty (36)
  6. Center for Pancreatic Cancer Research (29)

More Groups

People
  1. Steven Larson (24)
  2. Jorge Carrasquillo (18)
  3. Mithat Gonen (17)
  4. Jason Lewis (15)
  5. Serge Lyashchenko (13)
  6. Joseph O'Donoghue (12)

More People

Years
  1. 2024 (2)
  2. 2023 (4)
  3. 2022 (5)
  4. 2021 (2)
  5. 2020 (3)
  6. 2019 (7)

More Years

Publications
  1. Journal of Nuclear Medicine (13)
  2. Journal of Clinical Oncology (10)
  3. Clinical Cancer Research (4)
  4. Pediatric Blood and Cancer (4)
  5. American Journal of Roentgenology (2)
  6. Clinical Colorectal Cancer (2)

More Publications

Publishers
  1. Society of Nuclear Medicine (13)
  2. American Society of Clinical Oncology (10)
  3. American Association for Cancer Research (5)
  4. Elsevier Inc. (5)
  5. Springer (4)
  6. Wiley Periodicals, Inc (4)

More Publishers

Results (51)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • High-dose naxitamab (humanized-3F8) plus stepped-up dosing of granulocyte-macrophage colony-stimulating factor for relapsed neuroblastoma resistant to salvage therapy: A phase II trial
    Meeting Abstract

    Kushner, B.; Modak, S.; Basu, E.; Roberts, S.; Mauguen, A.; Pandit-Taskar, N.; Cheung, N. K.
    Pediatric Blood and Cancer (2019)

    Fulltext@MSK | Save
  • A curative approach to central nervous system metastases of neuroblastoma
    Meeting Abstract

    Kramer, K.; Kushner, B.; Modak, S.; Pandit-Taskar, N.; Mauguen, A.; Tomlinson, U.; Wolden, S.; Zanzonico, P.; Humm, J.; Haque, S.; more...
    Pediatric Blood and Cancer (2019)

    Fulltext@MSK | Save
  • EGFR and MET amplifications determine response to HER2 inhibition in ERBB2-amplified esophagogastric cancer
    Journal Article

    Sanchez-Vega, F.; Hechtman, J. F.; Castel, P.; Ku, G. Y.; Tuvy, Y.; Won, H.; Fong, C. J.; Bouvier, N.; Nanjangud, G. J.; Soong, J.; more...
    Cancer Discovery (2019)

    Fulltext@MSK | Save
  • Assessment of organ dosimetry for planning repeat treatments of high-dose (131)I-MIBG therapy: (123)I-MIBG versus posttherapy (131)I-MIBG imaging
    Journal Article

    Pandit-Taskar, N.; Zanzonico, P.; Hilden, P.; Ostrovnaya, I.; Carrasquillo, J. A.; Modak, S.
    Clinical Nuclear Medicine (2017)

    Fulltext@MSK | Save
  • First-in-human imaging with (89)Zr-Df-IAB2M Anti-PSMA minibody in patients with metastatic prostate cancer: Pharmacokinetics, biodistribution, dosimetry, and lesion uptake
    Journal Article

    Pandit-Taskar, N.; O'Donoghue, J. A.; Ruan, S.; Lyashchenko, S. K.; Carrasquillo, J. A.; Heller, G.; Martinez, D. F.; Cheal, S. M.; Lewis, J. S.; Fleisher, M.; more...
    Journal of Nuclear Medicine (2016)

    Fulltext@MSK | Save
  • Surrogate imaging biomarkers of response of colorectal liver metastases after salvage radioembolization using (90)Y-loaded resin microspheres
    Journal Article

    Shady, W.; Sotirchos, V. S.; Do, R. K.; Pandit-Taskar, N.; Carrasquillo, J. A.; Gonen, M.; Sofocleous, C. T.
    American Journal of Roentgenology (2016)

    Fulltext@MSK | Save
  • A phase I/II study for analytic validation of 89Zr-J591 immunoPET as a molecular imaging agent for metastatic prostate cancer
    Journal Article

    Pandit-Taskar, N.; O'Donoghue, J. A.; Durack, J. C.; Lyashchenko, S. K.; Cheal, S. M.; Beylergil, V.; Lefkowitz, R. A.; Carrasquillo, J. A.; Martinez, D. F.; Fung, A. M.; more...
    Clinical Cancer Research (2015)

    Fulltext@MSK | Save
  • Radioembolization as a salvage therapy for heavily pretreated patients with colorectal cancer liver metastases: Factors that affect outcomes
    Journal Article

    Sofocleous, C. T.; Violari, E. G.; Sotirchos, V. S.; Shady, W.; Gonen, M.; Pandit-Taskar, N.; Petre, E. N.; Brody, L. A.; Alago, W.; Do, R. K.; more...
    Clinical Colorectal Cancer (2015)

    Fulltext@MSK | Save
  • Tumor-directed PET imaging of metastases in metastatic castration-resistant prostate cancer (mCRPC) using Zr-89 labeled antiprostate-specific membrane antigen (PSMA) antibody J591
    Meeting Abstract

    Feldman, J. L.; Morris, M. J.; Martinez, D. F.; Tagawa, S. T.; Nanus, D. M.; Solomon, S. B.; Carrasquillo, J. A.; Reuter, V. E.; Lewis, J. S.; O'Donoghue, J. A.; more...
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • Tumor-directed PET imaging of metastases in metastatic castration-resistant prostate cancer (mCRPC) using Zr-89 labeled antiprostate-specific membrane antigen (PSMA) antibody J591
    Meeting Abstract

    Feldman, J. L.; Morris, M. J.; Tagawa, S. T.; Nanus, D. M.; Solomon, S. B.; Carrasquillo, J. A.; Reuter, V. E.; Lewis, J. S.; O'Donoghue, J. A.; Martinez, D. F.; more...
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save